export const oxikodon = {
	id: 27,
	otcDrug: false,
	categories: "Analgesic",
	class: "1",
	activeSubstance: "Oxycodone",
	timeLimit: true,
	maxPeriod: "Oxycodone should not be used longer than necessary",
	interactionExists: true,

	name: "Oxynorm",
	dosage: "5mg",
	quantity: "14 capsules",
	drugGroup: "Opioid",
	imageUrl:
		"data:image/jpeg;base64,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 ",
	dosing: {
		adults:
			" The starting dose for patients who have not previously received opioids is 5 mg every 6 hours, but a higher starting dose may be required depending on the patient's need for pain control. If the pain responds to opioids, the dose can be increased every day until the required effect is achieved or unacceptable side effects occur. Patients who are already receiving opioids may, depending on previous experience, start with a higher OxyNorm dose. Opioids should be dosed individually due to large patient differences in pharmacokinetics, pain intensity, pain genesis, potential tolerance, body weight, gender (plasma concentrations are higher in women) and age",
		children:
			"OxyNorm should not be given to children under 18 years of age as there is a lack of experience in the treatment of these patient categories.",
	},
	maxDose: "",
	withMeal: false,
	betweenMeals: false,
	infants: false,
	adults: true,
	minAge: "18",
	pregnancy:
		"Experience with treatment during pregnancy is limited. During pregnancy, oxycodone should only be given on strict indication and after the mother's needs have been weighed against the risks to the baby.",
	breastfeeding:
		"Oxycodone passes into breast milk and can cause respiratory depression in the newborn baby. The concentration ratio between milk and plasma was 3.4:1. OxyNorm should therefore not be used during breastfeeding ",
	indications: [
		"Severe opioid-sensitive pain such as pain from cancer or after surgery.",
	],

	contraindications: [
		"Hypersensitivity to the active substance or to any excipient",
		"Severe chronic obstructive pulmonary disease.",
		"cor pulmonale",
		"severe bronchial asthma",
		"paralytic ileus",
		"severe respiratory depression with hypoxia and/or hypercapnia",
	],
	pharmacodynamics:
		" Oxycodone is an opioid with a strong analgesic effect. It is a pure opioid agonist with no antagonistic action. Its main action is through the myopioid receptors but affinity for delta or kappa opioid receptors has also been demonstrated. Its action resembles that of morphine. Oral oxycodone is equipotent with oral morphine in a 1:2 ratio, i.e. twice as strong as morphine. The analgesic effect depends partly on a changed pain experience and partly on an increase in the pain threshold. The mechanism of action involves CNS opioid receptors for the body's own compounds with opioid-like activity. Oxycodone exerts its analgesic effect at different levels within the CNS.",
	description:
		"Oxycodone is a narcotic-classified preparation used for very severe pain.Oxycodone may be habit-forming. Take oxycodone exactly as directed. Do not take more of it, take it more often, or take it in a different way than directed by your doctor .It may cause serious or life-threatening breathing problems, especially during the first 24 to 72 hours of your treatment and any time your dose is increased. ",
	interactions: [
		{
			name: "grapefruit juice",
			activeSubstance: "",
			drugGroup: [""],
			prescriptionDrug: false,
			indications: [""],
			interactionType: "D",
			consequence:
				"A moderate increase in oxycodone concentration is expected. ",
			suggestions:
				"Grapefruit juice should be avoided by patients treated with oxycodone.",
		},
		{
			name: "Alcohol",
			activeSubstance: "Etanol",
			drugGroup: [""],
			prescriptionDrug: false,
			indications: [""],
			interactionType: "D",
			consequence:
				"Mixing any opioid drug with alcohol is dangerous. Kodein binds to opioid receptors while alcohol affects the GABA receptors, both drugs interact with neurotransmitters, particularly dopamine and serotonin.Mixing opioids and alcohol increases the risk of overdose and long-term health damage.",
			suggestions: "Combination should be avoided",
		},
		{
			name: "Rimactan",
			activeSubstance: "Rifampicin",
			drugGroup: ["Antibiotics"],
			prescriptionDrug: true,
			indications: ["Tuberculosis"],
			interactionType: "D",
			consequence:
				"Exposure to oxycodone can be significantly reduced. The effect of oxycodone may be lost and/or opioid withdrawal symptoms may occur",
			suggestions: "Combination should be avoided",
		},
		{
			name: "Multaq",
			activeSubstance: "Dronedaron",
			drugGroup: ["Antiarrhythmics"],
			prescriptionDrug: true,
			indications: ["Atrial fibrillation"],
			interactionType: "D",
			consequence:
				"Concentration of oxycodone can increase, which increases the risk of serious side effects such as sedation and respiratory depression. ",
			suggestions:
				"Combination should be avoided. If concomitant treatment is deemed necessary, oxycodone should be given in a lower starting dose and the dose titrated up depending on clinical effect",
		},
	],

	sideEffects: [
		"constipation",
		"fatigue",
		"abdominal pain",
		"nausea",
		"decreased appetite",
		"anxiety",
		"confusion",
		"depression",
		"insomnia",
		"nervousness",
		"abnormal thinking",
		"somnolence",
		"dizziness",
		"headache",
		"tremor",
		"bronchial",
		"spasm",
	],
};
